Susan Monarez
Susan Monarez | |
|---|---|
 Monarez in 2025 | |
| Acting Director of the Centers for Disease Control and Prevention | |
| Assumed office January 23, 2025 | |
| President | Donald Trump |
| Deputy | Nirav D. Shah (acting) |
| Preceded by | Mandy Cohen |
| Personal details | |
| Education | University of Wisconsin–Madison |
Susan Coller Monarez is an American health scientist who is Principal Deputy Director of the Centers for Disease Control and Prevention (CDC) since 2025. She is currently also serving as the Acting Director of CDC. She was previously Deputy Director of the Advanced Research Projects Agency for Health.
Education
Monarez completed her Ph.D. at the University of Wisconsin–Madison, where her research focused on developing technologies to prevent, diagnose, and treat infectious diseases, particularly those affecting low- and middle-income countries.[1] She was a postdoctoral researcher at Stanford University School of Medicine, continuing her work in the field of infectious disease research.[1]
Career
Monarez was a Science and Technology Policy Fellow with the American Association for the Advancement of Science.[1] She held roles in the Office of Science and Technology Policy and the U.S. National Security Council, where her work included initiatives to combat antimicrobial resistance, expand the use of wearable technology for health monitoring, and improve pandemic preparedness efforts.[1][2]
At the U.S. Department of Homeland Security, Monarez served as Deputy Assistant Secretary for Strategy and Data Analytics, overseeing research portfolios for the Homeland Security Advanced Research Projects Agency (HSARPA) and the Biomedical Advanced Research and Development Authority. In this capacity, she also led international cooperative initiatives to foster bilateral and multilateral collaboration in health research and innovation.[1]
In January 2023, Monarez was appointed Deputy Director of the Advanced Research Projects Agency for Health (ARPA-H), where she led projects focused on applying artificial intelligence and machine learning to improve health outcomes, addressing healthcare accessibility and affordability, expanding mental health interventions, combating the opioid epidemic in the United States, addressing disparities in maternal health, and improving organ donation and transplantation systems.[1][2]
Monarez became Acting Director of the Centers for Disease Control and Prevention (CDC) and Acting Administrator of the Agency for Toxic Substances and Disease Registry on January 23, 2025, after being named as the agency's Principal Deputy Director. Her leadership responsibilities at the CDC include overseeing responses to public health emergencies and emerging diseases.[2][3]
References
- ^ a b c d e f "Susan Monarez". Advanced Research Projects Agency for Health. Archived from the original on January 26, 2025. Retrieved January 26, 2025.
This article incorporates text from this source, which is in the public domain.
- ^ a b c "Acting Director, First Assistant to the Director, Principal Deputy Director". Centers for Disease Control and Prevention. January 24, 2025. Archived from the original on January 26, 2025. Retrieved January 26, 2025. This article incorporates text from this source, which is in the public domain.
- ^ Tin, Alexander (January 23, 2025). "Trump administration expected to go outside CDC for acting director". CBS News. Retrieved January 26, 2025.